ArticleClinics (Sao Paulo, Brazil)2025

Commentary on "Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors".

Shubham Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.